Indeed, tyrosine kinase inhibitors may lead to hypophosphatemia and increased parathyroid hormone levels, with low–normal calcium levels, while immune checkpoint inhibitors may cause hypocalcemia and hypercalcemia. The gene discussed is PTH; the disease is hypophosphatemia.